vs

Side-by-side financial comparison of Bloomin' Brands, Inc. (BLMN) and CABOT CORP (CBT). Click either name above to swap in a different company.

Bloomin' Brands, Inc. is the larger business by last-quarter revenue ($975.2M vs $849.0M, roughly 1.1× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs -1.4%, a 10.0% gap on every dollar of revenue. On growth, Bloomin' Brands, Inc. posted the faster year-over-year revenue change (0.3% vs -11.1%). Bloomin' Brands, Inc. produced more free cash flow last quarter ($63.7M vs $57.0M). Over the past eight quarters, Bloomin' Brands, Inc.'s revenue compounded faster (-4.5% CAGR vs -8.7%).

Bloomin' Brands, Inc. is a restaurant holding company that owns several American casual dining restaurant chains. The company was established in 1988 in Tampa, Florida, where it is headquartered.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

BLMN vs CBT — Head-to-Head

Bigger by revenue
BLMN
BLMN
1.1× larger
BLMN
$975.2M
$849.0M
CBT
Growing faster (revenue YoY)
BLMN
BLMN
+11.4% gap
BLMN
0.3%
-11.1%
CBT
Higher net margin
CBT
CBT
10.0% more per $
CBT
8.6%
-1.4%
BLMN
More free cash flow
BLMN
BLMN
$6.7M more FCF
BLMN
$63.7M
$57.0M
CBT
Faster 2-yr revenue CAGR
BLMN
BLMN
Annualised
BLMN
-4.5%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BLMN
BLMN
CBT
CBT
Revenue
$975.2M
$849.0M
Net Profit
$-13.5M
$73.0M
Gross Margin
70.2%
24.9%
Operating Margin
-1.4%
15.2%
Net Margin
-1.4%
8.6%
Revenue YoY
0.3%
-11.1%
Net Profit YoY
83.0%
-21.5%
EPS (diluted)
$-0.16
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLMN
BLMN
CBT
CBT
Q4 25
$975.2M
$849.0M
Q3 25
$928.8M
$899.0M
Q2 25
$1.0B
$923.0M
Q1 25
$1.0B
$936.0M
Q4 24
$972.0M
$955.0M
Q3 24
$910.0M
$1.0B
Q2 24
$999.4M
$1.0B
Q1 24
$1.1B
$1.0B
Net Profit
BLMN
BLMN
CBT
CBT
Q4 25
$-13.5M
$73.0M
Q3 25
$-45.9M
$43.0M
Q2 25
$25.4M
$101.0M
Q1 25
$42.2M
$94.0M
Q4 24
$-79.5M
$93.0M
Q3 24
$6.9M
$137.0M
Q2 24
$28.4M
$109.0M
Q1 24
$-83.9M
$84.0M
Gross Margin
BLMN
BLMN
CBT
CBT
Q4 25
70.2%
24.9%
Q3 25
70.4%
24.5%
Q2 25
70.2%
26.4%
Q1 25
70.1%
25.7%
Q4 24
71.6%
24.6%
Q3 24
71.3%
24.0%
Q2 24
70.5%
25.2%
Q1 24
70.5%
24.1%
Operating Margin
BLMN
BLMN
CBT
CBT
Q4 25
-1.4%
15.2%
Q3 25
-3.9%
15.2%
Q2 25
3.0%
18.1%
Q1 25
5.5%
17.3%
Q4 24
1.7%
16.2%
Q3 24
0.9%
15.0%
Q2 24
4.4%
16.9%
Q1 24
6.6%
15.3%
Net Margin
BLMN
BLMN
CBT
CBT
Q4 25
-1.4%
8.6%
Q3 25
-4.9%
4.8%
Q2 25
2.5%
10.9%
Q1 25
4.0%
10.0%
Q4 24
-8.2%
9.7%
Q3 24
0.8%
13.7%
Q2 24
2.8%
10.7%
Q1 24
-7.8%
8.2%
EPS (diluted)
BLMN
BLMN
CBT
CBT
Q4 25
$-0.16
$1.37
Q3 25
$-0.54
$0.80
Q2 25
$0.30
$1.86
Q1 25
$0.50
$1.69
Q4 24
$-0.93
$1.67
Q3 24
$0.08
$2.41
Q2 24
$0.32
$1.94
Q1 24
$-0.96
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLMN
BLMN
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$59.5M
$230.0M
Total DebtLower is stronger
$787.4M
Stockholders' EquityBook value
$333.6M
$1.6B
Total Assets
$3.2B
$3.8B
Debt / EquityLower = less leverage
2.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLMN
BLMN
CBT
CBT
Q4 25
$59.5M
$230.0M
Q3 25
$66.5M
$258.0M
Q2 25
$50.3M
$239.0M
Q1 25
$57.7M
$213.0M
Q4 24
$70.1M
$183.0M
Q3 24
$83.6M
$223.0M
Q2 24
$117.9M
$197.0M
Q1 24
$131.7M
$206.0M
Total Debt
BLMN
BLMN
CBT
CBT
Q4 25
$787.4M
Q3 25
$962.2M
$1.1B
Q2 25
$917.1M
Q1 25
$917.6M
Q4 24
$1.0B
Q3 24
$1.1B
$1.1B
Q2 24
$1.0B
Q1 24
$951.8M
Stockholders' Equity
BLMN
BLMN
CBT
CBT
Q4 25
$333.6M
$1.6B
Q3 25
$344.1M
$1.6B
Q2 25
$397.2M
$1.5B
Q1 25
$380.6M
$1.4B
Q4 24
$135.5M
$1.4B
Q3 24
$242.1M
$1.4B
Q2 24
$286.8M
$1.3B
Q1 24
$302.7M
$1.4B
Total Assets
BLMN
BLMN
CBT
CBT
Q4 25
$3.2B
$3.8B
Q3 25
$3.3B
$3.8B
Q2 25
$3.3B
$3.8B
Q1 25
$3.3B
$3.8B
Q4 24
$3.4B
$3.6B
Q3 24
$3.4B
$3.7B
Q2 24
$3.4B
$3.6B
Q1 24
$3.4B
$3.6B
Debt / Equity
BLMN
BLMN
CBT
CBT
Q4 25
2.36×
Q3 25
2.80×
0.70×
Q2 25
2.31×
Q1 25
2.41×
Q4 24
7.58×
Q3 24
4.51×
0.75×
Q2 24
3.49×
Q1 24
3.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLMN
BLMN
CBT
CBT
Operating Cash FlowLast quarter
$119.1M
$126.0M
Free Cash FlowOCF − Capex
$63.7M
$57.0M
FCF MarginFCF / Revenue
6.5%
6.7%
Capex IntensityCapex / Revenue
5.7%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$96.8M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLMN
BLMN
CBT
CBT
Q4 25
$119.1M
$126.0M
Q3 25
$34.4M
$219.0M
Q2 25
$49.7M
$249.0M
Q1 25
$73.5M
$73.0M
Q4 24
$119.8M
$124.0M
Q3 24
$-7.8M
$204.0M
Q2 24
$42.4M
$207.0M
Q1 24
$73.8M
$176.0M
Free Cash Flow
BLMN
BLMN
CBT
CBT
Q4 25
$63.7M
$57.0M
Q3 25
$-5.7M
$155.0M
Q2 25
$11.1M
$188.0M
Q1 25
$27.7M
$1.0M
Q4 24
$66.7M
$47.0M
Q3 24
$-67.3M
$112.0M
Q2 24
$-12.1M
$155.0M
Q1 24
$20.0M
$133.0M
FCF Margin
BLMN
BLMN
CBT
CBT
Q4 25
6.5%
6.7%
Q3 25
-0.6%
17.2%
Q2 25
1.1%
20.4%
Q1 25
2.6%
0.1%
Q4 24
6.9%
4.9%
Q3 24
-7.4%
11.2%
Q2 24
-1.2%
15.3%
Q1 24
1.9%
13.1%
Capex Intensity
BLMN
BLMN
CBT
CBT
Q4 25
5.7%
8.1%
Q3 25
4.3%
7.1%
Q2 25
3.8%
6.6%
Q1 25
4.4%
7.7%
Q4 24
5.5%
8.1%
Q3 24
6.5%
9.2%
Q2 24
5.5%
5.1%
Q1 24
5.0%
4.2%
Cash Conversion
BLMN
BLMN
CBT
CBT
Q4 25
1.73×
Q3 25
5.09×
Q2 25
1.95×
2.47×
Q1 25
1.74×
0.78×
Q4 24
1.33×
Q3 24
-1.13×
1.49×
Q2 24
1.49×
1.90×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLMN
BLMN

Food And Beverage$958.0M98%
Franchiseand Other Revenue$17.2M2%
International Franchise Segment$7.8M1%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons